• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Emergent Biosolutions Inc

+ Add to Watchlist

ER4:GR

16.750 EUR 0.105 0.62%

As of 02:08:58 ET on 07/11/2014.

Snapshot for Emergent Biosolutions Inc (ER4)

Open: 16.746 Day's Range: 16.585 - 16.750 Volume: 0
Previous Close: 16.855 52wk Range: 12.513 - 20.170 1-Yr Rtn: +36.29%

Stock Chart for ER4

No chart data available.
  • ER4:GR 16.746
  • 1D
  • 1M
  • 1Y
16.855
Interactive ER4 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ER4

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 21.7000
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 1.0500
Est. PEG Ratio -
Market Cap (M EUR) 626.64
Shares Outstanding (M) 37.41
30 Day Average Volume 21
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ER4

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ER4

Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.

Fuad El-HibriChairmanDaniel J Abdun-NabiPresident/CEO
Adam HaveyExec VP/President:BiodefenseBarry A LabingerExec VP/Pres:Biosciences Div
More Company Profile & Key Executives for ER4

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil